Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)
Clinical trial NCT05046795 · COMPLETED
Trial details
- NCT number
- NCT05046795
- Sponsor
- Mylan Pharma UK Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2023-07-26
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.